Nantahala Capital Management, LLC

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Nantahala Capital Management, LLC's trades of Evoke Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
466.71
Quantity 6,705 +17.5%
Value US$3,132,222
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-30 2025-01-28
S Sale
6,705 +17.5%
466.71
US$3,132,222 		6,705 +17.5% 466.71 US$3,132,222
2019-06-17 2019-06-14
S Sale
77,427 +28.9%
18.45
US$470,771 		77,427 +28.9% 18.45 US$470,771
2019-06-17 2019-06-13
S Sale
18,748 +48.2%
486.78
US$4,961,543 		18,748 +48.2% 486.78 US$4,961,543